Saturday, 27 February 2021

Feb 2021 Update

Feb 2021

Portfolio Value after market close

S$130,363.45

Purchase

None

Sold

ISOTeam @ 50,000 shares
CapitaLand @ 4,000 shares

Dividends
 
Suntec Reit @ $90.44

Short-Term Transactions

SPCE, NAKD, CHMA, SOS, SCKT, LODE

Summary

01 Feb 2021 STI Open: 2,896.32
26 Feb 2021 STI Close: 2,949.04
 
STI closed above its opening this month though we saw dips across the broad market for the last couple of days. 
 
I sold ISOTeam and CapitaLand at net 67.5% loss and 19.3% profit respectively. 

Reasons for selling will be explained below. 

The funds will mostly likely be redeployed to either Ascendas Reit, CapitaLand China Trust or
Mapletree Industrial Trust. 

I have made my pick if yesterday's closing price is anything to go by.

This is part of my portfolio rebalancing which I have wanted to adopt a more active approach this year.  

I also intend to open a Syfe Equity100 portfolio with a small portion of the funds for managed investment in the overseas markets. 

However I understand Syfe will be introducing a new product early next month so I'll wait for that to see how it compares to the existing offerings. 

I continued to dabble with the US market this month with my initial small amount which is one that won't make me lose my sleep and which is something that I can afford to lose. 

I consider this portion as my fun account / portfolio. 

Little to no due diligence are done for this account. The trades are mostly based on momentum and price actions. The trades are also mainly intraday with tight stop losses. 

ISOTeam

Sold it on 23rd Feb 2021 at $0.125 with a 67.5% net loss after dividends.

Surprisingly, I don't feel pain at all. It's like a mechanical, 'has to be done' move for me. 

ISOTeam purchase was initiated about 4 years ago. The government was pumping billions into the construction industry which was already doing quite well.

My reasoning was that since I do not fancy investing into construction companies with their lumpy earnings (although I did contemplate about HLS for quite a long period due to its juicy dividends back then), I will invest into ISOTeam as a proxy to the industry. 

ISOTeam is an established player in HDB and town council projects with constant project wins. As such I thought their recurring income would be more attractive to investors. 

Unfortunately I was proven wrong. 

This counter has became more illiquid over the years. 

As a testament on how illiquid this counter is, I set sell order for nearly a week before my shares finally got sold.

There are several reasons that prompted me to sell. 

Firstly, when the broader market is recovering from the March lows this year,  ISOTeam's share price is still languishing near a 5 year low. 

Even the slew of contract wins failed to catalyse the share price. 

It just doesn't move in tandem with the market which likely points to company-specific reasons as per point 2 below. 

Secondly, deteriorating fundamentals. The continual compressed gross profit margin (GPM) which hit below 5% in the latest concluded FY makes me wonder whether the business is sustainable. 

A low margin might makes sense for commodities trading business which goes by higher volume. I.e. low margin high turnover. 

But being in the engineering projects business myself, a 5% GPM is certainly a cause for alarm and I don't think it is sustainable for an engineering company. 

One of the criteria I use for my stock screening is a net profit of minimum 10%. In this case ISOTeam is far off the mark (the GP is not even 10% let alone the net profit).  

In fact they made a net loss in the FY ended June 2020.

And if I remember correctly, operating cash flow went in the red last year. The management explained that it is due to ageing of the accounts and upfront payment of project expenses. 

Again, being in the engineering business myself, I don't find this normal at all. 

Thirdly, opportunity costs are mounting. With the local market gradually recovering from the March lows and the US market hitting record highs recently, I felt the need to capture the upswing of the markets. 

I'm pretty sure it is a good move to cut loss and move the funds to other growth stocks or dividend counters for my income portfolio. 

The sale of this dead wood also fulfilled one of my investment aims set earlier this year.

Lastly, poor outlook. The company has guided that the near term is going to remain challenging for them and I am of the same view.

Although their order book has >$100 million worth of projects to be delivered over the next 2 - 3 years, I believed the margin is in single digit.

Cost of sales is also likely to increase as per my personal encounters in the industry. If ISOTeam didn't take steps to lock in vendor prices, margin might be further hit.

The integration of Pure Group into ISOTeam also didn't turned up as well as anticipated with the former likely to be loss-making in 1H FY21.

With no dividends declared for last year and I expect it to be the same for this year, there is no incentive to wait for the share price recovery which I feel can only happen in either of the following ways - 1) Acquisition by another company or 2) Drastically improve on its fundamentals.

But for now, I'm off this counter.

CapitaLand

Sold it on 24th Feb 2021 at $3.15 with a 19.3% net profit after dividends.

CapitaLand is another one of my long held counters.

Over the years it has been providing me decent dividend yield (4% against cost which is my minimum criteria) while I wait for the share price to hit my TP.

Couple of years back it nearly hit $4. I attribute that to the strong management team led by the capable Mr Lim Ming Yan.

I decided to sell it this time after it reported its first full year net loss in almost two decades, although that is partly contributed to revaluation losses. 

Despite that, it upped its dividend payout ratio to pay a 9 cents dividend for 2020. This is lower than the 12 cents paid in previous years though. 

As such my yield has fallen to 3% against cost. Sell, and transfer the funds for an easy 5% yield elsewhere is the logical move for now.

I have no qualms to buy the shares again if the price is right. Hint: Oct 2020.

Friday, 29 January 2021

Jan 2021 Update

Jan 2021

Portfolio Value after market close

S$151,639.60

Purchase

None

Sold

None

Dividends
 
Singtel @ $408

Short-Term Transactions

BB, GME, PLTR, SOL, NOK, AMC, NAKD

Summary

04 Jan 2021 STI Open: 2,858.90
29 Jan 2021 STI Close: 2,902.52
 
STI closed above its opening this month but I don't feel particularly bullish about our local market. 
 
Nevertheless a pullback is always welcomed for opportunities to add. 

I also entered the US market this month which 'partially' fulfilled one of my aims mentioned earlier this year.

Why 'partially'? 

Because this is driven in a large part by the Wallstreetbets (WSB) euphoria. 

I have to admit I am gambling more than investing. No due diligence was made when I placed the trades. I was merely riding on the momentum created by the WSB crowd and betting on the anticipated short squeeze.

This is the reason why I am only betting a small percentage of my portfolio and the wonderful millions of profits shown on Reddit is unlikely to occur in my case.

In a way I find myself enjoying the process more than the profits. 

Enjoy while it last.

And by the way, to the trading houses that stop retailers from trading GME and AMC last night, hope you get your retribution soon. 

Monday, 4 January 2021

2020: A Year in Review

Time really flew past in 2020 and it's time for a review of the year again.
 
Here is goes. 

Family

We have a new addition to our family in 2020. Our son arrived safe and sound in August to meet his parents and sister.

This means less personal time for myself but more bonding time with kids on the other hand.

It's a hard juggle some times though.

Our hope is for our kids to grow up healthy, happily and with the right values in life.

Healthy Lifestyle

My health in the past year is generally good except for the last week of the year where I came down with a sore throat. 
 
I think that was the first time I visited a doctor in 2 ~ 3 years.
 
Other than that I am pleased and thankful for the healthy body in an otherwise unhealthy year for the world.
 
Earlier this year I came up with an exercise regime that can be done at home. It trains most of the major muscle groups of the body and combine resistance training with cardio respiratory training.

I've blogged about it here previously.
 
I did the training almost daily till July / August where I stopped and the effect on the body is pretty visible. Both internally and externally.
 
I have restarted the training this week and hope to do it as often as my time allows.
 
Guess this, together with the cold showers that I've taken since years ago, really helps to keep one healthy. 

Oh the cold weather these few days makes the showers even shioker!
 
Recently I have also attended a certified personal trainer course to learn how to train more effectively. Hopefully I can pass with flying colours.

Work

With my financial year ending in February 2021, I still have two months to charge ahead.
 
Results so far for this FY are terrible. Business secured and project value both dropped tremendously.

This FY is expected to be a loss-making year.
 
The circuit breaker earlier this year means no new business coming in for most part of the year. Projects that were in discussion were put on hold. And I couldn't go out for sales talk due to the travel and social distancing restrictions.
 
But no excuses here. I should have work harder.
 
On the bright side, I made use of the time to get some certifications for the company which will come in useful especially when bidding for public projects.
 
Good thing is that the company is still surviving due to the good performance of the past two years.

Hopefully this year onwards we can more than cover the shortfall of the precedent year.

Moving forward, my focus is to grow the business and start hiring if company performance improves.

Financials and Other Incomes

Previously I have set these targets for 2020.

Targeted Passive Income Actual Passive Income Achieved
$7,200.00 $6,687.14 vs $4,471.25 in 20199
Targeted Side Income Actual Side Income Achieved
$6,000.00 $2,563.49 vs $5,314.78 in 20199

Results: Both targets not achieved.

For 2021,

Targeted passive income: S$8,900
Targeted side income: S$11,500

Investments

Received my last round of dividends for the year in December consisting of:
 
1) ESR REIT @ $79.80
2) MNACT @ $115.04
3) Netlink Trust @ $202.40
4) DBS @ $108
5) MLT @ $201.30
6) CRCT @ $220
7) Ascendas REIT @ $287
 
Total: $1,213.54
 
Moving forward investment-wise, my plan for this year is to:
 
1. Get rid of the dead wood in my portfolio (was planning to do it last month but the price had a drastic fall on the day I wanted to sell)
 
2. Allocate a portion of my investments into crypto currencies (probably 1% of my portfolio for a start)

3. Invest into the US market

My investment style remains the same: Income investing.
 
Hence main focus will still be concentrated in the local companies where the yield is still attractive.
 
My holdings as of 31/12/2020:

S/N Counter No. of Shares Cost incl. Fees Price at 31/12/2020 Value at 31/12/2020
1 OCBC 1,055 $9,310.49 $10.060 $10,613.30
2 SingTel 8,000 $25,820.21 $2.310 $18,480.00
3 CICT 5,400 $9,307.87 $2.160 $11,664.00
4 Suntec REIT 4,000 $6,629.59 $1.490 $5,960.00
5 CapitaLand 4,000 $11,969.70 $3.280 $13,120.00
6 ISOTeam 50,000 $21,070.79 $0.130 $6,500.00
7 Netlink Trust 8,000 $6,337.19 $0.965 $7,720.00
8 Mapletree Logistic Trust 10,000 $13,820.80 $2.010 $20,100.00
9 RHT Health Trust 10,000 $1,460.58 $0.019 $190.00
10 ESR REIT 10,000 $5,334.46 $0.395 $3,950.00
11 Mapletree NAC Trust 4,000 $4,455.20 $0.970 $3,880.00
12 Ascendas REIT 7,000 $20,419.89 $2.980 $20,860.00
13 CRCT 9,100 $12,973.67 $1.390 $12,649.00
14 DBS 600 $13,148.49 $25.040 $15,024.00
        Total Value: $150,710.30
 
Took part in several preferential offers in 2020 including Mapletree Logistic Trust, Ascendas REIT and CapitaLand Retail China Trust with the latter two happening in the last month of the year.
 
Also applied for excess for all three POs and received it for both MLT and Ascendas.

For CRCT, I had applied for a total of 13,000 units (allocation + excess) but ended up only getting 4,000 units.
 
All the above are quality businesses which I have no qualms in taking the opportunities presented to add to my investments.

Back in March 2020, I have identified CRCT, DBS and OCBC among the counters in my watch list to focus my funds on.

So far I have added 3 batches of CRCT and 2 batches of DBS and OCBC each.
 
As of year end 2020, number of holdings in my portfolio increased to 14 counters compared to 13 in 2019.
 
Portfolio value at end of the year increased to S$150,710 (vs S$122,453 in 2019).
 
Tabulated summary:

Year end portfolio cost incl. fees $162,059
Year end portfolio value $150,710
2020 dividend collected $6,094
2020 net realised P/L $3,516
Total accumulative dividend collected $22,029
Total invested to long term portfolio in 2020 $59,269
 
Again, the overall portfolio was dragged down by ISOTeam which I have the intention to realise the loss and place the remaining fund elsewhere.

Other than that, the realised P&L is a positive.


My transactions for 2020:

S/N Counter No. of Shares Cost incl. Fees Type
1 OCBC 500 $4,615.63 Bought
2 OCBC 500 $4,257.27 Bought
3 OCBC 31 $241.49 Bought
4 SingTel 3,000 $7,452.73 Bought
5 CCT 3,500 $5,716.86 Bought
6 Mapletree Logistic Trust 2,483 $4,942.17 Bought
7 Japfa 10,000 $5,002.00 Bought
8 Japfa 40,000 $24,716.05 Sold
9 Ascendas REIT 2,000 $5,921.00 Bought
10 Ascendas REIT 5,000 $13,596.40 Bought
11 Ascendas REIT 5,000 $13,902.24 Sold
12 CRCT 5,000 $7,680.40 Bought
13 CRCT 3,000 $4,005.27 Bought
14 CRCT 1,100 $1,288.00 Bought
15 DBS 300 $7,194.36 Bought
16 DBS 300 $5,954.13 Bought
17 DLC SG5xShort DBS 5,000 $6,275.00 Bought
18 DLC SG5xShort DBS 5,000 $5,075.00 Sold
19 DLC SG5xShort DBS 10,000 $17,800.00 Bought
20 DLC SG5xShort DBS 10,000 $15,300.00 Sold
21 DLC SG5xShort SIA 10,000 $8,027.55 Bought
22 DLC SG5xShort SIA 10,000 $7,794.96 Sold
23 Keppel DC REIT 5,000 $11,519.69 Bought
24 Keppel DC REIT 5,000 $11,709.77 Sold
         
    Total Bought: $121,489.95  
    Total Sold: $78,498.02  
 
Quite a number of transactions done for my standard. Unfortunately not all turned out to be good trades.
 
Highlights include averaged down on Japfa in batches which turned in a profit and some bad trades on DLCs.
 
Hopefully I will improve on my trading skills in the year ahead.
 
Lastly, here's wishing everyone a blessed and healthy 2021.